Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

2 Injured in Crash on North Palisades Drive


2 Vehicles Collide in Pacific Palisades Accident

Pacific Palisades, CA (March 30, 2020) – Two people suffered serious injuries in a rollover crash in Pacific Palisades. The accident occurred on the afternoon of March 30 on North Palisades Drive.

Two vehicles collided in the 1100 block of North Palisades Drive. One vehicle overturned. Both drivers were trapped inside their vehicles. Both drivers were removed by firefighters. Both were seriously injured and taken to local hospitals for treatment. 

#Pacific Palisades 

#90272


May 1, 2020

Pedestrian Injured in Crash on Interstate 805 Near Imperial Avenue

Victim Hit by Car in San Diego Accident...


October 3, 2019

Man Injured in Pedestrian Crash at Laning Road and Rosecrans Street

Victim Suffers Head Injury in San Diego Accident San Diego, CA (October 1, 2019...


November 15, 2019

Motorcyclist Killed in Crash on Guerneville Road

Motorcycle, Train Collide in Fatal Santa Rosa Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.